vTv Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2015

HIGH POINT, N.C.--(BUSINESS WIRE)--vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer’s disease (AD) and diabetes, today reported financial results for the third quarter of 2015 and provided an update on recent developments.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC